476 related articles for article (PubMed ID: 27226803)
1. Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.
Alavian SM; Haghbin H
Hepat Mon; 2016 Mar; 16(3):e35106. PubMed ID: 27226803
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries.
Madihi S; Syed H; Lazar F; Zyad A; Benani A
Biomed Res Int; 2020; 2020():7027169. PubMed ID: 32626758
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis.
Sadeghi F; Salehi-Vaziri M; Almasi-Hashiani A; Gholami-Fesharaki M; Pakzad R; Alavian SM
Hepat Mon; 2016 Apr; 16(4):e35558. PubMed ID: 27274353
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis.
Lehman EM; Wilson ML
Int J Cancer; 2009 Feb; 124(3):690-7. PubMed ID: 18973270
[TBL] [Abstract][Full Text] [Related]
5. The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis.
Babanejad M; Izadi N; Najafi F; Alavian SM
Hepat Mon; 2016 Mar; 16(3):e35664. PubMed ID: 27226804
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
7. Systematic overview of hepatitis C infection in the Middle East and North Africa.
Chaabna K; Cheema S; Abraham A; Alrouh H; Lowenfels AB; Maisonneuve P; Mamtani R
World J Gastroenterol; 2018 Jul; 24(27):3038-3054. PubMed ID: 30038471
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.
Zidan A; Scheuerlein H; Schüle S; Settmacher U; Rauchfuss F
Hepat Mon; 2012 Oct; 12(10 HCC):e6894. PubMed ID: 23233864
[TBL] [Abstract][Full Text] [Related]
9. Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis.
Alavian SM; Aalaei-Andabili SH
Hepat Mon; 2012 Apr; 12(4):244-52. PubMed ID: 22690231
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in Asia: Prevention strategy and planning.
Ashtari S; Pourhoseingholi MA; Sharifian A; Zali MR
World J Hepatol; 2015 Jun; 7(12):1708-17. PubMed ID: 26140091
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for hepatocellular carcinoma in India.
Kar P
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S34-42. PubMed ID: 25755609
[TBL] [Abstract][Full Text] [Related]
12. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI
JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699
[TBL] [Abstract][Full Text] [Related]
13. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.
de Martel C; Maucort-Boulch D; Plummer M; Franceschi S
Hepatology; 2015 Oct; 62(4):1190-200. PubMed ID: 26146815
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.
Amini N; Alavian SM; Kabir A; Aalaei-Andabili SH; Saiedi Hosseini SY; Rizzetto M
Hepat Mon; 2013 Jan; 13(1):e8210. PubMed ID: 23554822
[TBL] [Abstract][Full Text] [Related]
15. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
Abruzzi A; Fried B; Alikhan SB
Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
[TBL] [Abstract][Full Text] [Related]
16. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
17. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center.
Wang M; Wang Y; Feng X; Wang R; Wang Y; Zeng H; Qi J; Zhao H; Li N; Cai J; Qu C
Int J Infect Dis; 2017 Dec; 65():15-21. PubMed ID: 28935244
[TBL] [Abstract][Full Text] [Related]
18. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
Aljumah AA; Kuriry H; Faisal N; Alghamdi H
Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
[TBL] [Abstract][Full Text] [Related]
20. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
Di Bisceglie AM; Simpson LH; Lotze MT; Hoofnagle JH
J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
